Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial

Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial

Abstract Background Multidrug-resistant tuberculosis (MDR-TB) are unsatisfied to treat, pressing more effective and innovative treatment regimens. New efficient regimens for MDR-TB have obtained high treatment success rates. However, those regimens without drug susceptibility testing (DST) are also...

Full description

Bibliographic Details
Main Authors: Taoping Weng, Feng Sun, Yang Li, Jiazhen Chen, Xinchang Chen, Rong Li, Shijia Ge, Yanlin Zhao, Wenhong Zhang
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Infectious Diseases
Subjects:
Tuberculosis
Multidrug-resistant tuberculosis
Multicenter
Randomized trial
Non-inferiority
Precision treatments
Online Access:https://doi.org/10.1186/s12879-021-05870-w

Internet

https://doi.org/10.1186/s12879-021-05870-w

Similar Items